Bukwang Pharmaceutical saw the highest growth of 199% in patent filings and 99% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 199% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Bukwang Pharmaceutical‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Bukwang Pharmaceutical has been focused on protecting inventions in European Patent Office(EPO) with five publications in Q4 2023

The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 50% filings and 33% grants. The European Patent Office(EPO), China(CN), World Intellectual Property Organization(WIPO), and Germany(DE) patent Office are among the top ten patent offices where Bukwang Pharmaceutical is filings its patents. Among the top granted patent authorities, Bukwang Pharmaceutical has 33% of its grants in European Patent Office(EPO), 33% in Germany(DE) and 33% in Japan(JP).

Movement disorders related patents lead Bukwang Pharmaceutical portfolio followed by dyskinesia, and parkinson's disease

Bukwang Pharmaceutical has highest number of patents in movement disorders followed by dyskinesia, parkinson's disease.

For comprehensive analysis of Bukwang Pharmaceutical's filings and grants, buy the databook here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.